November 17 and 18: SOVECI 20th Annual Meeting, 2023

We invite the entire community to take part in the annual meeting of the Venezuelan Society of Interventional Cardiology (SOVECI). This prestigious event will take place on November 17 and 18 at the Eurobuilding Hotel in Caracas, Venezuela.

SOVECI 2023 is an excellent opportunity for cardiologists, including other expert physicians, fellows, cardiopulmonary nurses and technicians, to advance their knowledge and connect with colleagues and experts in the field of interventional cardiology.

Main Topics at SOVECI 2023:

  • Master lectures on the latest advances in coronary and peripheral interventionism, structural and congenital heart disease, electrophysiology and cardiac stimulation, and cardiovascular surgery. 
  • Live and edited cases.
  • SOVECI / SOLACI / SOPHIE live symposium
  • Symposium for nurses and technicians. 

    Congreso SOVECI 2023


    Subscribe to our weekly newsletter

    Get the latest scientific articles on interventional cardiology

More articles by this author

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

SOLACI-CACI 2024 – Presentations day 3

Discover the highlights of the third day of activities of  SOLACI-CACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires, Argentina. Dr....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...